- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
HHS Funds Support Efforts to Certify Community Behavioral Health Clinics
Twenty-four states have received grants to improve the behavioral health of their citizens by providing community-based mental and substance use disorder treatment.
The Substance Abuse and Mental Health Services Administration (SAMHSA), in conjunction with CMS and the Assistant Secretary of Planning and Evaluation (ASPE), has awarded $229 million in planning grants to help states throughout the nation to improve the behavioral health of their citizens by providing community-based mental and substance use disorder treatment. Twenty-four states have received grants ranging from $728,054 to $982,373.
The grants will help states strengthen payment for behavioral health services for Medicaid and Children’s Health Insurance Program (CHIP) beneficiaries, and will help those with mental and substance abuse disorders get the healthcare they need to maintain their health and well-being, said Vikki Wachio, deputy administrator of CMS and director of the Center for Medicaid and CHIP Services.
The populations to be served are adults with serious mental illness, children with serious emotional disturbance, and those with long-term and serious substance use disorders, as well as others with mental illness and substance use disorders.
The planning grants are part of a comprehensive plan to integrate behavioral and physical healthcare, use evidence-based practices more consistently, and improve access to high-quality care. The grants will be used to support states’ efforts to certify community behavioral health clinics and establish prospective payment systems for demonstration reimbursable services, and prepare applications to participate in the demonstration program.
The planning grants are the first phase of a two-phase process. When the planning grant phase ends in October 2016, grant awardees will have the chance to apply to participate in a 2-year demonstration program that begins January 2017. Through the demonstration program, up to eight states with certified community behavioral health clinics will provide behavioral health services to eligible beneficiaries and be paid using an approved prospective payment system.
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
March 15th 2025The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Technology Takes Center Stage at the 2025 AAD Annual Meeting
March 14th 2025The role of artificial intelligence, DataDerm, and telehealth in advancing dermatology care was discussed throughout the meeting, with experts highlighting their potential regarding patient access and health equity.
Read More
Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy
March 13th 2025The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.
Read More
